Large Volume Parenterals Comprehensive Study by Type (Fluid Balance Injections, Therapeutic Injections, Nutritious Injections), Application (Intravenous, Intramuscular, Subcutaneous, Others), Volume (100 ml - 250 ml, 250 ml - 500 ml, 500 ml - 1000 ml, 1000 ml - 2000 ml, 2000 ml and more), Packaging (Bottles, Bags), End User (Hospitals & Other Healthcare Facilities, Home Care) Players and Region - Global Market Outlook to 2030

Large Volume Parenterals Market by XX Submarkets | Forecast Years 2024-2030  

  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled

Report Objectives / Segmentation Covered

By Type
  • Fluid Balance Injections
  • Therapeutic Injections
  • Nutritious Injections
By Application
  • Intravenous
  • Intramuscular
  • Subcutaneous
  • Others
By Volume
  • 100 ml - 250 ml
  • 250 ml - 500 ml
  • 500 ml - 1000 ml
  • 1000 ml - 2000 ml
  • 2000 ml and more

By Packaging
  • Bottles
  • Bags

By End User
  • Hospitals & Other Healthcare Facilities
  • Home Care

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Hospitalization Rate
      • 3.2.2. Rising Number of Surgeries
    • 3.3. Market Challenges
      • 3.3.1. Formulation of LVPs
    • 3.4. Market Trends
      • 3.4.1. Rise in Demand for Faster, Safer and Effective Administration of Drugs
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Large Volume Parenterals, by Type, Application, Volume, Packaging, End User and Region (value) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Large Volume Parenterals (Value)
      • 5.2.1. Global Large Volume Parenterals by: Type (Value)
        • 5.2.1.1. Fluid Balance Injections
        • 5.2.1.2. Therapeutic Injections
        • 5.2.1.3. Nutritious Injections
      • 5.2.2. Global Large Volume Parenterals by: Application (Value)
        • 5.2.2.1. Intravenous
        • 5.2.2.2. Intramuscular
        • 5.2.2.3. Subcutaneous
        • 5.2.2.4. Others
      • 5.2.3. Global Large Volume Parenterals by: Volume (Value)
        • 5.2.3.1. 100 ml - 250 ml
        • 5.2.3.2. 250 ml - 500 ml
        • 5.2.3.3. 500 ml - 1000 ml
        • 5.2.3.4. 1000 ml - 2000 ml
        • 5.2.3.5. 2000 ml and more
      • 5.2.4. Global Large Volume Parenterals by: Packaging (Value)
        • 5.2.4.1. Bottles
        • 5.2.4.2. Bags
      • 5.2.5. Global Large Volume Parenterals by: End User (Value)
        • 5.2.5.1. Hospitals & Other Healthcare Facilities
        • 5.2.5.2. Home Care
      • 5.2.6. Global Large Volume Parenterals Region
        • 5.2.6.1. South America
          • 5.2.6.1.1. Brazil
          • 5.2.6.1.2. Argentina
          • 5.2.6.1.3. Rest of South America
        • 5.2.6.2. Asia Pacific
          • 5.2.6.2.1. China
          • 5.2.6.2.2. Japan
          • 5.2.6.2.3. India
          • 5.2.6.2.4. South Korea
          • 5.2.6.2.5. Taiwan
          • 5.2.6.2.6. Australia
          • 5.2.6.2.7. Rest of Asia-Pacific
        • 5.2.6.3. Europe
          • 5.2.6.3.1. Germany
          • 5.2.6.3.2. France
          • 5.2.6.3.3. Italy
          • 5.2.6.3.4. United Kingdom
          • 5.2.6.3.5. Netherlands
          • 5.2.6.3.6. Rest of Europe
        • 5.2.6.4. MEA
          • 5.2.6.4.1. Middle East
          • 5.2.6.4.2. Africa
        • 5.2.6.5. North America
          • 5.2.6.5.1. United States
          • 5.2.6.5.2. Canada
          • 5.2.6.5.3. Mexico
  • 6. Large Volume Parenterals: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Ostuka Pharmaceutical (Japan)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Teva Pharmaceutical Industries Limited (Israel)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Kelun Pharma (China)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Cook Pharmica LLC (Catalent) (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Patheon Inc. (Netherlands)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. BAG Healthcare (Germany)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Southwest Pharmaceutical Co. Ltd. (China)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
  • 7. Global Large Volume Parenterals Sale, by Type, Application, Volume, Packaging, End User and Region (value) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Large Volume Parenterals (Value)
      • 7.2.1. Global Large Volume Parenterals by: Type (Value)
        • 7.2.1.1. Fluid Balance Injections
        • 7.2.1.2. Therapeutic Injections
        • 7.2.1.3. Nutritious Injections
      • 7.2.2. Global Large Volume Parenterals by: Application (Value)
        • 7.2.2.1. Intravenous
        • 7.2.2.2. Intramuscular
        • 7.2.2.3. Subcutaneous
        • 7.2.2.4. Others
      • 7.2.3. Global Large Volume Parenterals by: Volume (Value)
        • 7.2.3.1. 100 ml - 250 ml
        • 7.2.3.2. 250 ml - 500 ml
        • 7.2.3.3. 500 ml - 1000 ml
        • 7.2.3.4. 1000 ml - 2000 ml
        • 7.2.3.5. 2000 ml and more
      • 7.2.4. Global Large Volume Parenterals by: Packaging (Value)
        • 7.2.4.1. Bottles
        • 7.2.4.2. Bags
      • 7.2.5. Global Large Volume Parenterals by: End User (Value)
        • 7.2.5.1. Hospitals & Other Healthcare Facilities
        • 7.2.5.2. Home Care
      • 7.2.6. Global Large Volume Parenterals Region
        • 7.2.6.1. South America
          • 7.2.6.1.1. Brazil
          • 7.2.6.1.2. Argentina
          • 7.2.6.1.3. Rest of South America
        • 7.2.6.2. Asia Pacific
          • 7.2.6.2.1. China
          • 7.2.6.2.2. Japan
          • 7.2.6.2.3. India
          • 7.2.6.2.4. South Korea
          • 7.2.6.2.5. Taiwan
          • 7.2.6.2.6. Australia
          • 7.2.6.2.7. Rest of Asia-Pacific
        • 7.2.6.3. Europe
          • 7.2.6.3.1. Germany
          • 7.2.6.3.2. France
          • 7.2.6.3.3. Italy
          • 7.2.6.3.4. United Kingdom
          • 7.2.6.3.5. Netherlands
          • 7.2.6.3.6. Rest of Europe
        • 7.2.6.4. MEA
          • 7.2.6.4.1. Middle East
          • 7.2.6.4.2. Africa
        • 7.2.6.5. North America
          • 7.2.6.5.1. United States
          • 7.2.6.5.2. Canada
          • 7.2.6.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Large Volume Parenterals: by Type(USD Million)
  • Table 2. Large Volume Parenterals Fluid Balance Injections , by Region USD Million (2018-2023)
  • Table 3. Large Volume Parenterals Therapeutic Injections , by Region USD Million (2018-2023)
  • Table 4. Large Volume Parenterals Nutritious Injections , by Region USD Million (2018-2023)
  • Table 5. Large Volume Parenterals: by Application(USD Million)
  • Table 6. Large Volume Parenterals Intravenous , by Region USD Million (2018-2023)
  • Table 7. Large Volume Parenterals Intramuscular , by Region USD Million (2018-2023)
  • Table 8. Large Volume Parenterals Subcutaneous , by Region USD Million (2018-2023)
  • Table 9. Large Volume Parenterals Others , by Region USD Million (2018-2023)
  • Table 10. Large Volume Parenterals: by Volume(USD Million)
  • Table 11. Large Volume Parenterals 100 ml - 250 ml , by Region USD Million (2018-2023)
  • Table 12. Large Volume Parenterals 250 ml - 500 ml , by Region USD Million (2018-2023)
  • Table 13. Large Volume Parenterals 500 ml - 1000 ml , by Region USD Million (2018-2023)
  • Table 14. Large Volume Parenterals 1000 ml - 2000 ml , by Region USD Million (2018-2023)
  • Table 15. Large Volume Parenterals 2000 ml and more , by Region USD Million (2018-2023)
  • Table 16. Large Volume Parenterals: by Packaging(USD Million)
  • Table 17. Large Volume Parenterals Bottles , by Region USD Million (2018-2023)
  • Table 18. Large Volume Parenterals Bags , by Region USD Million (2018-2023)
  • Table 19. Large Volume Parenterals: by End User(USD Million)
  • Table 20. Large Volume Parenterals Hospitals & Other Healthcare Facilities , by Region USD Million (2018-2023)
  • Table 21. Large Volume Parenterals Home Care , by Region USD Million (2018-2023)
  • Table 22. South America Large Volume Parenterals, by Country USD Million (2018-2023)
  • Table 23. South America Large Volume Parenterals, by Type USD Million (2018-2023)
  • Table 24. South America Large Volume Parenterals, by Application USD Million (2018-2023)
  • Table 25. South America Large Volume Parenterals, by Volume USD Million (2018-2023)
  • Table 26. South America Large Volume Parenterals, by Packaging USD Million (2018-2023)
  • Table 27. South America Large Volume Parenterals, by End User USD Million (2018-2023)
  • Table 28. Brazil Large Volume Parenterals, by Type USD Million (2018-2023)
  • Table 29. Brazil Large Volume Parenterals, by Application USD Million (2018-2023)
  • Table 30. Brazil Large Volume Parenterals, by Volume USD Million (2018-2023)
  • Table 31. Brazil Large Volume Parenterals, by Packaging USD Million (2018-2023)
  • Table 32. Brazil Large Volume Parenterals, by End User USD Million (2018-2023)
  • Table 33. Argentina Large Volume Parenterals, by Type USD Million (2018-2023)
  • Table 34. Argentina Large Volume Parenterals, by Application USD Million (2018-2023)
  • Table 35. Argentina Large Volume Parenterals, by Volume USD Million (2018-2023)
  • Table 36. Argentina Large Volume Parenterals, by Packaging USD Million (2018-2023)
  • Table 37. Argentina Large Volume Parenterals, by End User USD Million (2018-2023)
  • Table 38. Rest of South America Large Volume Parenterals, by Type USD Million (2018-2023)
  • Table 39. Rest of South America Large Volume Parenterals, by Application USD Million (2018-2023)
  • Table 40. Rest of South America Large Volume Parenterals, by Volume USD Million (2018-2023)
  • Table 41. Rest of South America Large Volume Parenterals, by Packaging USD Million (2018-2023)
  • Table 42. Rest of South America Large Volume Parenterals, by End User USD Million (2018-2023)
  • Table 43. Asia Pacific Large Volume Parenterals, by Country USD Million (2018-2023)
  • Table 44. Asia Pacific Large Volume Parenterals, by Type USD Million (2018-2023)
  • Table 45. Asia Pacific Large Volume Parenterals, by Application USD Million (2018-2023)
  • Table 46. Asia Pacific Large Volume Parenterals, by Volume USD Million (2018-2023)
  • Table 47. Asia Pacific Large Volume Parenterals, by Packaging USD Million (2018-2023)
  • Table 48. Asia Pacific Large Volume Parenterals, by End User USD Million (2018-2023)
  • Table 49. China Large Volume Parenterals, by Type USD Million (2018-2023)
  • Table 50. China Large Volume Parenterals, by Application USD Million (2018-2023)
  • Table 51. China Large Volume Parenterals, by Volume USD Million (2018-2023)
  • Table 52. China Large Volume Parenterals, by Packaging USD Million (2018-2023)
  • Table 53. China Large Volume Parenterals, by End User USD Million (2018-2023)
  • Table 54. Japan Large Volume Parenterals, by Type USD Million (2018-2023)
  • Table 55. Japan Large Volume Parenterals, by Application USD Million (2018-2023)
  • Table 56. Japan Large Volume Parenterals, by Volume USD Million (2018-2023)
  • Table 57. Japan Large Volume Parenterals, by Packaging USD Million (2018-2023)
  • Table 58. Japan Large Volume Parenterals, by End User USD Million (2018-2023)
  • Table 59. India Large Volume Parenterals, by Type USD Million (2018-2023)
  • Table 60. India Large Volume Parenterals, by Application USD Million (2018-2023)
  • Table 61. India Large Volume Parenterals, by Volume USD Million (2018-2023)
  • Table 62. India Large Volume Parenterals, by Packaging USD Million (2018-2023)
  • Table 63. India Large Volume Parenterals, by End User USD Million (2018-2023)
  • Table 64. South Korea Large Volume Parenterals, by Type USD Million (2018-2023)
  • Table 65. South Korea Large Volume Parenterals, by Application USD Million (2018-2023)
  • Table 66. South Korea Large Volume Parenterals, by Volume USD Million (2018-2023)
  • Table 67. South Korea Large Volume Parenterals, by Packaging USD Million (2018-2023)
  • Table 68. South Korea Large Volume Parenterals, by End User USD Million (2018-2023)
  • Table 69. Taiwan Large Volume Parenterals, by Type USD Million (2018-2023)
  • Table 70. Taiwan Large Volume Parenterals, by Application USD Million (2018-2023)
  • Table 71. Taiwan Large Volume Parenterals, by Volume USD Million (2018-2023)
  • Table 72. Taiwan Large Volume Parenterals, by Packaging USD Million (2018-2023)
  • Table 73. Taiwan Large Volume Parenterals, by End User USD Million (2018-2023)
  • Table 74. Australia Large Volume Parenterals, by Type USD Million (2018-2023)
  • Table 75. Australia Large Volume Parenterals, by Application USD Million (2018-2023)
  • Table 76. Australia Large Volume Parenterals, by Volume USD Million (2018-2023)
  • Table 77. Australia Large Volume Parenterals, by Packaging USD Million (2018-2023)
  • Table 78. Australia Large Volume Parenterals, by End User USD Million (2018-2023)
  • Table 79. Rest of Asia-Pacific Large Volume Parenterals, by Type USD Million (2018-2023)
  • Table 80. Rest of Asia-Pacific Large Volume Parenterals, by Application USD Million (2018-2023)
  • Table 81. Rest of Asia-Pacific Large Volume Parenterals, by Volume USD Million (2018-2023)
  • Table 82. Rest of Asia-Pacific Large Volume Parenterals, by Packaging USD Million (2018-2023)
  • Table 83. Rest of Asia-Pacific Large Volume Parenterals, by End User USD Million (2018-2023)
  • Table 84. Europe Large Volume Parenterals, by Country USD Million (2018-2023)
  • Table 85. Europe Large Volume Parenterals, by Type USD Million (2018-2023)
  • Table 86. Europe Large Volume Parenterals, by Application USD Million (2018-2023)
  • Table 87. Europe Large Volume Parenterals, by Volume USD Million (2018-2023)
  • Table 88. Europe Large Volume Parenterals, by Packaging USD Million (2018-2023)
  • Table 89. Europe Large Volume Parenterals, by End User USD Million (2018-2023)
  • Table 90. Germany Large Volume Parenterals, by Type USD Million (2018-2023)
  • Table 91. Germany Large Volume Parenterals, by Application USD Million (2018-2023)
  • Table 92. Germany Large Volume Parenterals, by Volume USD Million (2018-2023)
  • Table 93. Germany Large Volume Parenterals, by Packaging USD Million (2018-2023)
  • Table 94. Germany Large Volume Parenterals, by End User USD Million (2018-2023)
  • Table 95. France Large Volume Parenterals, by Type USD Million (2018-2023)
  • Table 96. France Large Volume Parenterals, by Application USD Million (2018-2023)
  • Table 97. France Large Volume Parenterals, by Volume USD Million (2018-2023)
  • Table 98. France Large Volume Parenterals, by Packaging USD Million (2018-2023)
  • Table 99. France Large Volume Parenterals, by End User USD Million (2018-2023)
  • Table 100. Italy Large Volume Parenterals, by Type USD Million (2018-2023)
  • Table 101. Italy Large Volume Parenterals, by Application USD Million (2018-2023)
  • Table 102. Italy Large Volume Parenterals, by Volume USD Million (2018-2023)
  • Table 103. Italy Large Volume Parenterals, by Packaging USD Million (2018-2023)
  • Table 104. Italy Large Volume Parenterals, by End User USD Million (2018-2023)
  • Table 105. United Kingdom Large Volume Parenterals, by Type USD Million (2018-2023)
  • Table 106. United Kingdom Large Volume Parenterals, by Application USD Million (2018-2023)
  • Table 107. United Kingdom Large Volume Parenterals, by Volume USD Million (2018-2023)
  • Table 108. United Kingdom Large Volume Parenterals, by Packaging USD Million (2018-2023)
  • Table 109. United Kingdom Large Volume Parenterals, by End User USD Million (2018-2023)
  • Table 110. Netherlands Large Volume Parenterals, by Type USD Million (2018-2023)
  • Table 111. Netherlands Large Volume Parenterals, by Application USD Million (2018-2023)
  • Table 112. Netherlands Large Volume Parenterals, by Volume USD Million (2018-2023)
  • Table 113. Netherlands Large Volume Parenterals, by Packaging USD Million (2018-2023)
  • Table 114. Netherlands Large Volume Parenterals, by End User USD Million (2018-2023)
  • Table 115. Rest of Europe Large Volume Parenterals, by Type USD Million (2018-2023)
  • Table 116. Rest of Europe Large Volume Parenterals, by Application USD Million (2018-2023)
  • Table 117. Rest of Europe Large Volume Parenterals, by Volume USD Million (2018-2023)
  • Table 118. Rest of Europe Large Volume Parenterals, by Packaging USD Million (2018-2023)
  • Table 119. Rest of Europe Large Volume Parenterals, by End User USD Million (2018-2023)
  • Table 120. MEA Large Volume Parenterals, by Country USD Million (2018-2023)
  • Table 121. MEA Large Volume Parenterals, by Type USD Million (2018-2023)
  • Table 122. MEA Large Volume Parenterals, by Application USD Million (2018-2023)
  • Table 123. MEA Large Volume Parenterals, by Volume USD Million (2018-2023)
  • Table 124. MEA Large Volume Parenterals, by Packaging USD Million (2018-2023)
  • Table 125. MEA Large Volume Parenterals, by End User USD Million (2018-2023)
  • Table 126. Middle East Large Volume Parenterals, by Type USD Million (2018-2023)
  • Table 127. Middle East Large Volume Parenterals, by Application USD Million (2018-2023)
  • Table 128. Middle East Large Volume Parenterals, by Volume USD Million (2018-2023)
  • Table 129. Middle East Large Volume Parenterals, by Packaging USD Million (2018-2023)
  • Table 130. Middle East Large Volume Parenterals, by End User USD Million (2018-2023)
  • Table 131. Africa Large Volume Parenterals, by Type USD Million (2018-2023)
  • Table 132. Africa Large Volume Parenterals, by Application USD Million (2018-2023)
  • Table 133. Africa Large Volume Parenterals, by Volume USD Million (2018-2023)
  • Table 134. Africa Large Volume Parenterals, by Packaging USD Million (2018-2023)
  • Table 135. Africa Large Volume Parenterals, by End User USD Million (2018-2023)
  • Table 136. North America Large Volume Parenterals, by Country USD Million (2018-2023)
  • Table 137. North America Large Volume Parenterals, by Type USD Million (2018-2023)
  • Table 138. North America Large Volume Parenterals, by Application USD Million (2018-2023)
  • Table 139. North America Large Volume Parenterals, by Volume USD Million (2018-2023)
  • Table 140. North America Large Volume Parenterals, by Packaging USD Million (2018-2023)
  • Table 141. North America Large Volume Parenterals, by End User USD Million (2018-2023)
  • Table 142. United States Large Volume Parenterals, by Type USD Million (2018-2023)
  • Table 143. United States Large Volume Parenterals, by Application USD Million (2018-2023)
  • Table 144. United States Large Volume Parenterals, by Volume USD Million (2018-2023)
  • Table 145. United States Large Volume Parenterals, by Packaging USD Million (2018-2023)
  • Table 146. United States Large Volume Parenterals, by End User USD Million (2018-2023)
  • Table 147. Canada Large Volume Parenterals, by Type USD Million (2018-2023)
  • Table 148. Canada Large Volume Parenterals, by Application USD Million (2018-2023)
  • Table 149. Canada Large Volume Parenterals, by Volume USD Million (2018-2023)
  • Table 150. Canada Large Volume Parenterals, by Packaging USD Million (2018-2023)
  • Table 151. Canada Large Volume Parenterals, by End User USD Million (2018-2023)
  • Table 152. Mexico Large Volume Parenterals, by Type USD Million (2018-2023)
  • Table 153. Mexico Large Volume Parenterals, by Application USD Million (2018-2023)
  • Table 154. Mexico Large Volume Parenterals, by Volume USD Million (2018-2023)
  • Table 155. Mexico Large Volume Parenterals, by Packaging USD Million (2018-2023)
  • Table 156. Mexico Large Volume Parenterals, by End User USD Million (2018-2023)
  • Table 157. Company Basic Information, Sales Area and Its Competitors
  • Table 158. Company Basic Information, Sales Area and Its Competitors
  • Table 159. Company Basic Information, Sales Area and Its Competitors
  • Table 160. Company Basic Information, Sales Area and Its Competitors
  • Table 161. Company Basic Information, Sales Area and Its Competitors
  • Table 162. Company Basic Information, Sales Area and Its Competitors
  • Table 163. Company Basic Information, Sales Area and Its Competitors
  • Table 164. Large Volume Parenterals: by Type(USD Million)
  • Table 165. Large Volume Parenterals Fluid Balance Injections , by Region USD Million (2025-2030)
  • Table 166. Large Volume Parenterals Therapeutic Injections , by Region USD Million (2025-2030)
  • Table 167. Large Volume Parenterals Nutritious Injections , by Region USD Million (2025-2030)
  • Table 168. Large Volume Parenterals: by Application(USD Million)
  • Table 169. Large Volume Parenterals Intravenous , by Region USD Million (2025-2030)
  • Table 170. Large Volume Parenterals Intramuscular , by Region USD Million (2025-2030)
  • Table 171. Large Volume Parenterals Subcutaneous , by Region USD Million (2025-2030)
  • Table 172. Large Volume Parenterals Others , by Region USD Million (2025-2030)
  • Table 173. Large Volume Parenterals: by Volume(USD Million)
  • Table 174. Large Volume Parenterals 100 ml - 250 ml , by Region USD Million (2025-2030)
  • Table 175. Large Volume Parenterals 250 ml - 500 ml , by Region USD Million (2025-2030)
  • Table 176. Large Volume Parenterals 500 ml - 1000 ml , by Region USD Million (2025-2030)
  • Table 177. Large Volume Parenterals 1000 ml - 2000 ml , by Region USD Million (2025-2030)
  • Table 178. Large Volume Parenterals 2000 ml and more , by Region USD Million (2025-2030)
  • Table 179. Large Volume Parenterals: by Packaging(USD Million)
  • Table 180. Large Volume Parenterals Bottles , by Region USD Million (2025-2030)
  • Table 181. Large Volume Parenterals Bags , by Region USD Million (2025-2030)
  • Table 182. Large Volume Parenterals: by End User(USD Million)
  • Table 183. Large Volume Parenterals Hospitals & Other Healthcare Facilities , by Region USD Million (2025-2030)
  • Table 184. Large Volume Parenterals Home Care , by Region USD Million (2025-2030)
  • Table 185. South America Large Volume Parenterals, by Country USD Million (2025-2030)
  • Table 186. South America Large Volume Parenterals, by Type USD Million (2025-2030)
  • Table 187. South America Large Volume Parenterals, by Application USD Million (2025-2030)
  • Table 188. South America Large Volume Parenterals, by Volume USD Million (2025-2030)
  • Table 189. South America Large Volume Parenterals, by Packaging USD Million (2025-2030)
  • Table 190. South America Large Volume Parenterals, by End User USD Million (2025-2030)
  • Table 191. Brazil Large Volume Parenterals, by Type USD Million (2025-2030)
  • Table 192. Brazil Large Volume Parenterals, by Application USD Million (2025-2030)
  • Table 193. Brazil Large Volume Parenterals, by Volume USD Million (2025-2030)
  • Table 194. Brazil Large Volume Parenterals, by Packaging USD Million (2025-2030)
  • Table 195. Brazil Large Volume Parenterals, by End User USD Million (2025-2030)
  • Table 196. Argentina Large Volume Parenterals, by Type USD Million (2025-2030)
  • Table 197. Argentina Large Volume Parenterals, by Application USD Million (2025-2030)
  • Table 198. Argentina Large Volume Parenterals, by Volume USD Million (2025-2030)
  • Table 199. Argentina Large Volume Parenterals, by Packaging USD Million (2025-2030)
  • Table 200. Argentina Large Volume Parenterals, by End User USD Million (2025-2030)
  • Table 201. Rest of South America Large Volume Parenterals, by Type USD Million (2025-2030)
  • Table 202. Rest of South America Large Volume Parenterals, by Application USD Million (2025-2030)
  • Table 203. Rest of South America Large Volume Parenterals, by Volume USD Million (2025-2030)
  • Table 204. Rest of South America Large Volume Parenterals, by Packaging USD Million (2025-2030)
  • Table 205. Rest of South America Large Volume Parenterals, by End User USD Million (2025-2030)
  • Table 206. Asia Pacific Large Volume Parenterals, by Country USD Million (2025-2030)
  • Table 207. Asia Pacific Large Volume Parenterals, by Type USD Million (2025-2030)
  • Table 208. Asia Pacific Large Volume Parenterals, by Application USD Million (2025-2030)
  • Table 209. Asia Pacific Large Volume Parenterals, by Volume USD Million (2025-2030)
  • Table 210. Asia Pacific Large Volume Parenterals, by Packaging USD Million (2025-2030)
  • Table 211. Asia Pacific Large Volume Parenterals, by End User USD Million (2025-2030)
  • Table 212. China Large Volume Parenterals, by Type USD Million (2025-2030)
  • Table 213. China Large Volume Parenterals, by Application USD Million (2025-2030)
  • Table 214. China Large Volume Parenterals, by Volume USD Million (2025-2030)
  • Table 215. China Large Volume Parenterals, by Packaging USD Million (2025-2030)
  • Table 216. China Large Volume Parenterals, by End User USD Million (2025-2030)
  • Table 217. Japan Large Volume Parenterals, by Type USD Million (2025-2030)
  • Table 218. Japan Large Volume Parenterals, by Application USD Million (2025-2030)
  • Table 219. Japan Large Volume Parenterals, by Volume USD Million (2025-2030)
  • Table 220. Japan Large Volume Parenterals, by Packaging USD Million (2025-2030)
  • Table 221. Japan Large Volume Parenterals, by End User USD Million (2025-2030)
  • Table 222. India Large Volume Parenterals, by Type USD Million (2025-2030)
  • Table 223. India Large Volume Parenterals, by Application USD Million (2025-2030)
  • Table 224. India Large Volume Parenterals, by Volume USD Million (2025-2030)
  • Table 225. India Large Volume Parenterals, by Packaging USD Million (2025-2030)
  • Table 226. India Large Volume Parenterals, by End User USD Million (2025-2030)
  • Table 227. South Korea Large Volume Parenterals, by Type USD Million (2025-2030)
  • Table 228. South Korea Large Volume Parenterals, by Application USD Million (2025-2030)
  • Table 229. South Korea Large Volume Parenterals, by Volume USD Million (2025-2030)
  • Table 230. South Korea Large Volume Parenterals, by Packaging USD Million (2025-2030)
  • Table 231. South Korea Large Volume Parenterals, by End User USD Million (2025-2030)
  • Table 232. Taiwan Large Volume Parenterals, by Type USD Million (2025-2030)
  • Table 233. Taiwan Large Volume Parenterals, by Application USD Million (2025-2030)
  • Table 234. Taiwan Large Volume Parenterals, by Volume USD Million (2025-2030)
  • Table 235. Taiwan Large Volume Parenterals, by Packaging USD Million (2025-2030)
  • Table 236. Taiwan Large Volume Parenterals, by End User USD Million (2025-2030)
  • Table 237. Australia Large Volume Parenterals, by Type USD Million (2025-2030)
  • Table 238. Australia Large Volume Parenterals, by Application USD Million (2025-2030)
  • Table 239. Australia Large Volume Parenterals, by Volume USD Million (2025-2030)
  • Table 240. Australia Large Volume Parenterals, by Packaging USD Million (2025-2030)
  • Table 241. Australia Large Volume Parenterals, by End User USD Million (2025-2030)
  • Table 242. Rest of Asia-Pacific Large Volume Parenterals, by Type USD Million (2025-2030)
  • Table 243. Rest of Asia-Pacific Large Volume Parenterals, by Application USD Million (2025-2030)
  • Table 244. Rest of Asia-Pacific Large Volume Parenterals, by Volume USD Million (2025-2030)
  • Table 245. Rest of Asia-Pacific Large Volume Parenterals, by Packaging USD Million (2025-2030)
  • Table 246. Rest of Asia-Pacific Large Volume Parenterals, by End User USD Million (2025-2030)
  • Table 247. Europe Large Volume Parenterals, by Country USD Million (2025-2030)
  • Table 248. Europe Large Volume Parenterals, by Type USD Million (2025-2030)
  • Table 249. Europe Large Volume Parenterals, by Application USD Million (2025-2030)
  • Table 250. Europe Large Volume Parenterals, by Volume USD Million (2025-2030)
  • Table 251. Europe Large Volume Parenterals, by Packaging USD Million (2025-2030)
  • Table 252. Europe Large Volume Parenterals, by End User USD Million (2025-2030)
  • Table 253. Germany Large Volume Parenterals, by Type USD Million (2025-2030)
  • Table 254. Germany Large Volume Parenterals, by Application USD Million (2025-2030)
  • Table 255. Germany Large Volume Parenterals, by Volume USD Million (2025-2030)
  • Table 256. Germany Large Volume Parenterals, by Packaging USD Million (2025-2030)
  • Table 257. Germany Large Volume Parenterals, by End User USD Million (2025-2030)
  • Table 258. France Large Volume Parenterals, by Type USD Million (2025-2030)
  • Table 259. France Large Volume Parenterals, by Application USD Million (2025-2030)
  • Table 260. France Large Volume Parenterals, by Volume USD Million (2025-2030)
  • Table 261. France Large Volume Parenterals, by Packaging USD Million (2025-2030)
  • Table 262. France Large Volume Parenterals, by End User USD Million (2025-2030)
  • Table 263. Italy Large Volume Parenterals, by Type USD Million (2025-2030)
  • Table 264. Italy Large Volume Parenterals, by Application USD Million (2025-2030)
  • Table 265. Italy Large Volume Parenterals, by Volume USD Million (2025-2030)
  • Table 266. Italy Large Volume Parenterals, by Packaging USD Million (2025-2030)
  • Table 267. Italy Large Volume Parenterals, by End User USD Million (2025-2030)
  • Table 268. United Kingdom Large Volume Parenterals, by Type USD Million (2025-2030)
  • Table 269. United Kingdom Large Volume Parenterals, by Application USD Million (2025-2030)
  • Table 270. United Kingdom Large Volume Parenterals, by Volume USD Million (2025-2030)
  • Table 271. United Kingdom Large Volume Parenterals, by Packaging USD Million (2025-2030)
  • Table 272. United Kingdom Large Volume Parenterals, by End User USD Million (2025-2030)
  • Table 273. Netherlands Large Volume Parenterals, by Type USD Million (2025-2030)
  • Table 274. Netherlands Large Volume Parenterals, by Application USD Million (2025-2030)
  • Table 275. Netherlands Large Volume Parenterals, by Volume USD Million (2025-2030)
  • Table 276. Netherlands Large Volume Parenterals, by Packaging USD Million (2025-2030)
  • Table 277. Netherlands Large Volume Parenterals, by End User USD Million (2025-2030)
  • Table 278. Rest of Europe Large Volume Parenterals, by Type USD Million (2025-2030)
  • Table 279. Rest of Europe Large Volume Parenterals, by Application USD Million (2025-2030)
  • Table 280. Rest of Europe Large Volume Parenterals, by Volume USD Million (2025-2030)
  • Table 281. Rest of Europe Large Volume Parenterals, by Packaging USD Million (2025-2030)
  • Table 282. Rest of Europe Large Volume Parenterals, by End User USD Million (2025-2030)
  • Table 283. MEA Large Volume Parenterals, by Country USD Million (2025-2030)
  • Table 284. MEA Large Volume Parenterals, by Type USD Million (2025-2030)
  • Table 285. MEA Large Volume Parenterals, by Application USD Million (2025-2030)
  • Table 286. MEA Large Volume Parenterals, by Volume USD Million (2025-2030)
  • Table 287. MEA Large Volume Parenterals, by Packaging USD Million (2025-2030)
  • Table 288. MEA Large Volume Parenterals, by End User USD Million (2025-2030)
  • Table 289. Middle East Large Volume Parenterals, by Type USD Million (2025-2030)
  • Table 290. Middle East Large Volume Parenterals, by Application USD Million (2025-2030)
  • Table 291. Middle East Large Volume Parenterals, by Volume USD Million (2025-2030)
  • Table 292. Middle East Large Volume Parenterals, by Packaging USD Million (2025-2030)
  • Table 293. Middle East Large Volume Parenterals, by End User USD Million (2025-2030)
  • Table 294. Africa Large Volume Parenterals, by Type USD Million (2025-2030)
  • Table 295. Africa Large Volume Parenterals, by Application USD Million (2025-2030)
  • Table 296. Africa Large Volume Parenterals, by Volume USD Million (2025-2030)
  • Table 297. Africa Large Volume Parenterals, by Packaging USD Million (2025-2030)
  • Table 298. Africa Large Volume Parenterals, by End User USD Million (2025-2030)
  • Table 299. North America Large Volume Parenterals, by Country USD Million (2025-2030)
  • Table 300. North America Large Volume Parenterals, by Type USD Million (2025-2030)
  • Table 301. North America Large Volume Parenterals, by Application USD Million (2025-2030)
  • Table 302. North America Large Volume Parenterals, by Volume USD Million (2025-2030)
  • Table 303. North America Large Volume Parenterals, by Packaging USD Million (2025-2030)
  • Table 304. North America Large Volume Parenterals, by End User USD Million (2025-2030)
  • Table 305. United States Large Volume Parenterals, by Type USD Million (2025-2030)
  • Table 306. United States Large Volume Parenterals, by Application USD Million (2025-2030)
  • Table 307. United States Large Volume Parenterals, by Volume USD Million (2025-2030)
  • Table 308. United States Large Volume Parenterals, by Packaging USD Million (2025-2030)
  • Table 309. United States Large Volume Parenterals, by End User USD Million (2025-2030)
  • Table 310. Canada Large Volume Parenterals, by Type USD Million (2025-2030)
  • Table 311. Canada Large Volume Parenterals, by Application USD Million (2025-2030)
  • Table 312. Canada Large Volume Parenterals, by Volume USD Million (2025-2030)
  • Table 313. Canada Large Volume Parenterals, by Packaging USD Million (2025-2030)
  • Table 314. Canada Large Volume Parenterals, by End User USD Million (2025-2030)
  • Table 315. Mexico Large Volume Parenterals, by Type USD Million (2025-2030)
  • Table 316. Mexico Large Volume Parenterals, by Application USD Million (2025-2030)
  • Table 317. Mexico Large Volume Parenterals, by Volume USD Million (2025-2030)
  • Table 318. Mexico Large Volume Parenterals, by Packaging USD Million (2025-2030)
  • Table 319. Mexico Large Volume Parenterals, by End User USD Million (2025-2030)
  • Table 320. Research Programs/Design for This Report
  • Table 321. Key Data Information from Secondary Sources
  • Table 322. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Large Volume Parenterals: by Type USD Million (2018-2023)
  • Figure 5. Global Large Volume Parenterals: by Application USD Million (2018-2023)
  • Figure 6. Global Large Volume Parenterals: by Volume USD Million (2018-2023)
  • Figure 7. Global Large Volume Parenterals: by Packaging USD Million (2018-2023)
  • Figure 8. Global Large Volume Parenterals: by End User USD Million (2018-2023)
  • Figure 9. South America Large Volume Parenterals Share (%), by Country
  • Figure 10. Asia Pacific Large Volume Parenterals Share (%), by Country
  • Figure 11. Europe Large Volume Parenterals Share (%), by Country
  • Figure 12. MEA Large Volume Parenterals Share (%), by Country
  • Figure 13. North America Large Volume Parenterals Share (%), by Country
  • Figure 14. Global Large Volume Parenterals share by Players 2023 (%)
  • Figure 15. Global Large Volume Parenterals share by Players (Top 3) 2023(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Ostuka Pharmaceutical (Japan) Revenue, Net Income and Gross profit
  • Figure 18. Ostuka Pharmaceutical (Japan) Revenue: by Geography 2023
  • Figure 19. Teva Pharmaceutical Industries Limited (Israel) Revenue, Net Income and Gross profit
  • Figure 20. Teva Pharmaceutical Industries Limited (Israel) Revenue: by Geography 2023
  • Figure 21. Kelun Pharma (China) Revenue, Net Income and Gross profit
  • Figure 22. Kelun Pharma (China) Revenue: by Geography 2023
  • Figure 23. Cook Pharmica LLC (Catalent) (United States) Revenue, Net Income and Gross profit
  • Figure 24. Cook Pharmica LLC (Catalent) (United States) Revenue: by Geography 2023
  • Figure 25. Patheon Inc. (Netherlands) Revenue, Net Income and Gross profit
  • Figure 26. Patheon Inc. (Netherlands) Revenue: by Geography 2023
  • Figure 27. BAG Healthcare (Germany) Revenue, Net Income and Gross profit
  • Figure 28. BAG Healthcare (Germany) Revenue: by Geography 2023
  • Figure 29. Southwest Pharmaceutical Co. Ltd. (China) Revenue, Net Income and Gross profit
  • Figure 30. Southwest Pharmaceutical Co. Ltd. (China) Revenue: by Geography 2023
  • Figure 31. Global Large Volume Parenterals: by Type USD Million (2025-2030)
  • Figure 32. Global Large Volume Parenterals: by Application USD Million (2025-2030)
  • Figure 33. Global Large Volume Parenterals: by Volume USD Million (2025-2030)
  • Figure 34. Global Large Volume Parenterals: by Packaging USD Million (2025-2030)
  • Figure 35. Global Large Volume Parenterals: by End User USD Million (2025-2030)
  • Figure 36. South America Large Volume Parenterals Share (%), by Country
  • Figure 37. Asia Pacific Large Volume Parenterals Share (%), by Country
  • Figure 38. Europe Large Volume Parenterals Share (%), by Country
  • Figure 39. MEA Large Volume Parenterals Share (%), by Country
  • Figure 40. North America Large Volume Parenterals Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Ostuka Pharmaceutical (Japan)
  • Teva Pharmaceutical Industries Limited (Israel)
  • Kelun Pharma (China)
  • Cook Pharmica LLC (Catalent) (United States)
  • Patheon Inc. (Netherlands)
  • BAG Healthcare (Germany)
  • Southwest Pharmaceutical Co. Ltd. (China)
Additional players considered in the study are as follows:
Beximco Pharma (Bangladesh) , Baxter Healthcare Corporation (United States)
Select User Access Type

Key Highlights of Report


Mar 2024 229 Pages 70 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Know More About Global Large Volume Parenterals Report?